How CRISPR Future Shapes Up for Hot Genomics ETF

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is a star among healthcare exchange traded funds this year and CRISPR is a big reason why. Looking at the long-term outlook, ARKG includes companies that merge healthcare with technology and capitalize on the revolution in genomic...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.